Quality of Life in Patients with Autoimmune Bullous Disease (AIBD).
Background: Background: AIBD is a chronic dermatological condition of autoimmune origin, affecting skin and mucous membrane. Systemic corticosteroids are mainstay of treatment. Use of newer biologic Rituximab has been introduced in the last decade. Comprehensive studies reporting quality of life, factors affecting it are few in India.